Development of a quality of life measure for pharmaceutical physicians
Medical Affairs Pharmaceutical Physician Work-related Quality of Life (MAPPWrQoL) Instrument Development and Patient Registry (MAPPWrQoLReg)
This study is trying to create a tool that helps pharmaceutical doctors understand how their work affects their quality of life and to address the challenges they face.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 180 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medialis Ltd. Industry-sponsored |
| Locations | 1 site (Oxford) |
| Trial ID | NCT05123846 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a work-related quality of life measure specifically for medical affairs pharmaceutical physicians (MAPPs) who may experience occupational burnout due to a lack of recognition in their roles. The study will recruit 9 to 15 participants to provide insights into how their work impacts their quality of life using the Jandhyala Method. Participants will complete surveys to identify areas affected by work performance and will help create a tool that quantifies these impacts. The final tool will be designed to address the unique challenges faced by MAPPs in the pharmaceutical industry.
Who should consider this trial
Good fit: Ideal candidates for this study are qualified medical affairs pharmaceutical physicians with experience in the pharmaceutical industry.
Not a fit: Patients who are not currently working in the pharmaceutical industry or do not hold a medical degree may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recognition and support for MAPPs, enhancing their overall quality of life and mental well-being.
How similar studies have performed: While there may be studies focusing on quality of life in healthcare professionals, this specific approach for MAPPs is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Phase one and Phase two: Participants will be eligible to take part in Phase One based on the following criteria: * Qualification as a Medical Affairs Pharmaceutical Physician (qualified by medical degree). * Previous or current work experience within a pharmaceutical company (industry-based). * The participant can provide informed consent. * The participant can read, write, and converse in English. * The participant can comply with the study schedule. * 18 years and above. Exclusion Criteria: * Non-industry based Medical Affairs Pharmaceutical Physicians * Not able to comply with the study schedule * Not able to read, write, and converse in English.
Where this trial is running
Oxford
- Medialis — Oxford, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Ravi Jandhyala — Medialis Ltd.
- Study coordinator: Omolade Femi-Ajao, PhD
- Email: research@medialis.co.uk
- Phone: +447502228066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.